Pharos iBio Co., Ltd. Logo

Pharos iBio Co., Ltd.

AI-powered drug development for rare and refractory diseases, focusing on oncology.

388870 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 흥안대로427번길 38, 1408호(관양동, 성지스타위드), 안양시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Pharos iBio Co., Ltd. is a clinical-stage biotechnology company specializing in the development of novel drugs for rare and refractory diseases, with a particular focus on oncology. The company leverages its proprietary artificial intelligence (AI) and big data platform, Chemiverse®, to accelerate the drug discovery and development process. This platform integrates multiple modules, including protein structure analysis, to identify and optimize new drug candidates from target identification through to the preclinical stage. The company has successfully advanced its AI-developed therapies into clinical trials, notably for conditions like acute myeloid leukemia (AML), aiming to provide innovative treatments for patients with high unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-07-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-07-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-06-30 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (경구용 항암제 PHI101의 임상 1상 임상시험결과보고서(CSR) 수령)
Korean 14.4 KB
2025-06-26 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성…
Korean 15.8 KB
2025-06-25 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환…
Korean 12.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 956.3 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.3 KB
2025-03-25 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 18.2 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 364.5 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 26.0 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 173.4 KB
2025-03-05 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환자를 …
Korean 9.3 KB
2025-02-10 00:00
Regulatory News Service
주주총회소집결의
Korean 12.2 KB

Automate Your Workflow. Get a real-time feed of all Pharos iBio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharos iBio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.